1. Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors. Issue 2 (19th February 2021) Authors: Luke, Jason J; Barlesi, Fabrice; Chung, Ki; Tolcher, Anthony W; Kelly, Karen; Hollebecque, Antoine; Le Tourneau, Christophe; Subbiah, Vivek; Tsai, Frank; Kao, Steven; Cassier, Philippe A; Khasraw, Mustafa; Kindler, Hedy L; Fang, Hua; Fan, Frances; Allaire, Kathryn; Patel, Maulik; Ye, Shiming; Cha... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗